Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Plant protein showdown: oat vs. pea – which one digests best?

NCT ID NCT06142084

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study investigates how well different plant-based proteins (from oats and peas) are digested in the small intestine. Adults aged 18-75 with an ileostomy will consume protein meals on separate days, and the contents of their ileostomy bags will be analyzed to measure protein and amino acid absorption. The goal is to understand which plant proteins are more digestible and how they compare to lab-based models.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
plant-based proteins (oat and pea)
What this could lead to
If successful, this research could help design better plant-based protein sources and improve dietary recommendations for people with digestive conditions.
What could go wrong
This is a small, early-stage study with only 11 participants, so results may not apply to the general population. It measures digestion in people with ileostomies, which may differ from normal digestion.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 11 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age: 18 - 75 years * Body mass index: 18.5 - 30 kg/m2 * (double-loop) Ileostomy with an intact small bowel * Signed informed consent Exclusion Criteria: * Pregnancy or breastfeeding * Ileostomy \< 3 months before the study * Any clinically significant present or past disease/condition other than colon cancer which in the investigator's opinion could interfere with the results of the trial * Any clinically significant present or past medication which in the investigator's opinion could interfere with the results of the trial

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ileostomy - stoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Örebro University

    RECRUITING

    Örebro, 70182, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.